Eugene J. Segre

1.5k total citations
41 papers, 1.2k citations indexed

About

Eugene J. Segre is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Reproductive Medicine. According to data from OpenAlex, Eugene J. Segre has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 13 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Reproductive Medicine. Recurrent topics in Eugene J. Segre's work include Inflammatory mediators and NSAID effects (12 papers), Hormonal and reproductive studies (8 papers) and Ovarian function and disorders (7 papers). Eugene J. Segre is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Hormonal and reproductive studies (8 papers) and Ovarian function and disorders (7 papers). Eugene J. Segre collaborates with scholars based in United States, Mexico and Canada. Eugene J. Segre's co-authors include Richard Runkel, M. D. Chaplin, Hilli Sevelius, Enrico Forchielli, Gerhard Boost, Milan R. Henzl, Charles W. Lloyd, Eduardo Ortega, Julia Lobotsky and Edward L. Klaiber and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and The American Journal of Medicine.

In The Last Decade

Eugene J. Segre

41 papers receiving 941 citations

Peers

Eugene J. Segre

PHARM

EDM

Keri Wellington New Zealand

J.P. Desager Belgium

W. Kuhnz Germany

J Chakraborty United Kingdom

John F. Rogers United States

James J. Ferry United States

T G Rosano United States

Kent E. Opheim United States

Anthony M. Yurchak United States

A. Walan Sweden

Keri Wellington New Zealand

Eugene J. Segre

271 ×0.5

PHARM

225 ×1.0

PHARM

62 ×0.4

118 ×0.8

EDM

74 ×0.5

Citations per year, relative to Eugene J. Segre Eugene J. Segre (= 1×) peers Keri Wellington

Countries citing papers authored by Eugene J. Segre

Since Specialization

Citations

This map shows the geographic impact of Eugene J. Segre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene J. Segre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene J. Segre more than expected).

Fields of papers citing papers by Eugene J. Segre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene J. Segre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene J. Segre. The network helps show where Eugene J. Segre may publish in the future.

Co-authorship network of co-authors of Eugene J. Segre

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene J. Segre. A scholar is included among the top collaborators of Eugene J. Segre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene J. Segre. Eugene J. Segre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sevelius, Hilli, et al.. (1980). Comparative Analgesic Effects of Naproxen Sodium, Aspirin, and Placebo. The Journal of Clinical Pharmacology. 20(7). 480–485. 18 indexed citations

Chaplin, M. D., William C. Cooper, Eugene J. Segre, et al.. (1980). Correlation of flunisolide plasma levels to eosinopenic response in humans. Journal of Allergy and Clinical Immunology. 65(6). 445–453. 31 indexed citations

Segre, Eugene J.. (1979). Naproxen. Clinics in Rheumatic Diseases. 5(2). 411–426. 8 indexed citations

Mroszczak, Edward J., et al.. (1978). Cloprednol Bioavailability in Humans. Journal of Pharmaceutical Sciences. 67(7). 920–923. 2 indexed citations

Henzl, Milan R., et al.. (1977). The treatment of dysmenorrhea with naproxen sodium. American Journal of Obstetrics and Gynecology. 127(8). 818–823. 76 indexed citations

Willkens, Robert F. & Eugene J. Segre. (1976). Combination therapy with naproxen and aspirin in rheumatoid arthritis. Arthritis & Rheumatism. 19(4). 677–682. 40 indexed citations

Ortega, Eduardo, et al.. (1976). Metabolic Effects of Cloprednol—A New Systemic Corticosteroid. The Journal of Clinical Pharmacology. 16(2-3). 122–128. 6 indexed citations

Runkel, Richard, Enrico Forchielli, Hilli Sevelius, M. D. Chaplin, & Eugene J. Segre. (1974). Nonlinear plasma level response to high doses of naproxen. Clinical Pharmacology & Therapeutics. 15(3). 261–266. 107 indexed citations

Klaiber, Edward L., Milan R. Henzl, Charles W. Lloyd, & Eugene J. Segre. (1973). Corpus Luteum-Inhibiting Action of Oxymetholone. The Journal of Clinical Endocrinology & Metabolism. 36(1). 142–147. 15 indexed citations

10.

Sevelius, Hilli, et al.. (1973). Naproxen suppository: Tissue response and comparative bioavailability. European Journal of Clinical Pharmacology. 6(1). 22–25. 8 indexed citations

11.

Lussier, André, et al.. (1973). Naproxen: A novel approach to dose‐flnding efficacy trials in rheumatoid arthritis. Clinical Pharmacology & Therapeutics. 14(3). 434–441. 21 indexed citations

12.

Runkel, Richard, Enrico Forchielli, Gerhard Boost, et al.. (1973). Naproxen-Metabolism, Excretion and Comparative Pharmacokinetics. Scandinavian Journal of Rheumatology. 2(sup2). 29–36. 42 indexed citations

13.

Henzl, Milan R., et al.. (1973). Quantitation of the estrogenic effects of mestranol on human endometrium and vaginal mucosa. American Journal of Obstetrics and Gynecology. 115(3). 401–406. 7 indexed citations

14.

Henzl, Milan R., et al.. (1973). Oxymetholone: Differentiation between the ovarian and endometrial effects. American Journal of Obstetrics and Gynecology. 115(1). 95–100. 3 indexed citations

15.

Henzl, Milan R., et al.. (1973). Prostaglandin E₂and the Luteal Phase of the Menstrual Cycle: Effects on Blood Progesterone, Estradiol, Cortisol and Growth Hormone Levels1. The Journal of Clinical Endocrinology & Metabolism. 36(4). 784–787. 7 indexed citations

16.

Boost, Gerhard, et al.. (1972). Naproxen Oral Absorption Characteristics. Chemical and Pharmaceutical Bulletin. 20(7). 1457–1466. 34 indexed citations

17.

Kent, John R., et al.. (1972). Seminal acid phosphatase content in the clinical bioassay of androgens and antiandrogens. Clinical Pharmacology & Therapeutics. 13(2). 205–211. 4 indexed citations

18.

Runkel, Richard, M. D. Chaplin, Gerhard Boost, Eugene J. Segre, & Enrico Forchielli. (1972). Absorption, Distribution, Metabolism, and Excretion of Naproxen in Various Laboratory Animals and Human Subjects. Journal of Pharmaceutical Sciences. 61(5). 703–708. 142 indexed citations

19.

Brown, W. Ray, et al.. (1970). Progestational potency of chlormadinone acetate in the immature beagle bitch: Preliminary report. Contraception. 2(6). 381–390. 25 indexed citations

20.

Segre, Eugene J., Edward L. Klaiber, Julia Lobotsky, & Charles W. Lloyd. (1964). Hirsutism and Virilizing Syndromes. Annual Review of Medicine. 15(1). 315–334. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact